Biogen
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1978-01-01
- Employees
- 7.5K
- Market Cap
- $29.6B
- Website
- https://www.biogen.com
- Introduction
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMAD...
A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- Biogen
- Target Recruit Count
- 46
- Registration Number
- NCT04488133
- Locations
- 🇪🇸
Hospital Sant Joan de Déu, Esplugues Del Llobregat, Barcelona, Spain
🇺🇸University of Utah, Salt Lake City, Utah, United States
🇮🇹Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Milan, Italy
A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Biogen
- Target Recruit Count
- 440
- Registration Number
- NCT04476030
- Locations
- 🇺🇸
Sage Investigational Site, Bellevue, Washington, United States
A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Biogen
- Target Recruit Count
- 543
- Registration Number
- NCT04442490
- Locations
- 🇺🇸
Sage Investigational Site, Charlottesville, Virginia, United States
A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Biogen
- Target Recruit Count
- 200
- Registration Number
- NCT04442503
- Locations
- 🇬🇧
Sage Investigational Site, Maidstone, United Kingdom
🇺🇸Sage Investigational SIte, North Canton, Ohio, United States
🇺🇸Sage Investigational site, Charleston, South Carolina, United States
Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Biogen
- Target Recruit Count
- 50
- Registration Number
- NCT04419233
- Locations
- 🇨🇳
Research Site, Hangzhou, Zhejiang, China
Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)
- First Posted Date
- 2020-03-23
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Biogen
- Target Recruit Count
- 145
- Registration Number
- NCT04317794
- Locations
- 🇰🇷
Pusan Natioanl University Hospital, Busan, Korea, Republic of
🇰🇷Samsung Changwon Hospital, ChangWon, Korea, Republic of
🇰🇷Chungbuk National University Hospital, Cheongju-si, Korea, Republic of
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Biogen
- Target Recruit Count
- 75
- Registration Number
- NCT04288856
- Locations
- 🇬🇧
Research Site, Sheffield, South Yorkshire, United Kingdom
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Biogen
- Target Recruit Count
- 1696
- Registration Number
- NCT04241068
- Locations
- 🇨🇦
Montreal Neurological Institute Clinical Research Unit, Montréal, Quebec, Canada
🇫🇷CHU Lille - Hopital Roger Salengro, Lille Cedex, Nord, France
🇫🇷Hôpital Lariboisière, Paris cedex 10, Paris, France
Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP
- Conditions
- Interventions
- First Posted Date
- 2020-01-09
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Biogen
- Target Recruit Count
- 353
- Registration Number
- NCT04221191
- Locations
- 🇫🇷
Pole de Sante Du Plateau, Clamart, France
🇫🇷Cabinet du Dr Pierre Gras, Dijon, France
🇫🇷Cabinet médical Montebello, Lille, France
Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS
- Conditions
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Biogen
- Target Recruit Count
- 6
- Registration Number
- NCT04145284
- Locations
- 🇩🇪
Research Site, Dresden, Saxony, Germany